CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹936 Cr | ₹634 Cr | ₹567 Cr | ₹743 Cr | ₹622 Cr |
What is the latest Contingent Liabilities ratio of CIPLA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹936 Cr |
Mar2024 | ₹634 Cr |
Mar2023 | ₹567 Cr |
Mar2022 | ₹743 Cr |
Mar2021 | ₹622 Cr |
How is Contingent Liabilities of CIPLA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹936 Cr | 47.65 | |
Mar2024 | ₹634 Cr | 11.90 | |
Mar2023 | ₹567 Cr | -23.73 | |
Mar2022 | ₹743 Cr | 19.41 | |
Mar2021 | ₹622 Cr | - |
Compare Contingent Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹128,666.4 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,419.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,448.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
MANKIND PHARMA | ₹107,334.0 Cr | 1.6% | -5.3% | 7.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,539.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -1% |
4.8% |
-1.7% |
SENSEX | 1.8% |
-0.2% |
2% |
You may also like the below Video Courses